ASX - By Stock
|
IXC |
Re:
Ann: Top 20 Holders
|
|
ejjwj
|
89 |
24K |
1 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
89
|
24K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Top 20 Holders
|
|
ejjwj
|
89 |
24K |
1 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
89
|
24K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
ejjwj
|
40 |
9.4K |
3 |
25/04/23 |
25/04/23 |
ASX - By Stock
|
40
|
9.4K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
ejjwj
|
40 |
9.4K |
7 |
25/04/23 |
25/04/23 |
ASX - By Stock
|
40
|
9.4K
|
7
|
|
ASX - By Stock
|
IXC |
Re:
Ann: First Patient Randomised in IIH EVOLVE Phase III Trial
|
|
ejjwj
|
55 |
10K |
1 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
55
|
10K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: First Patient Randomised in IIH EVOLVE Phase III Trial
|
|
ejjwj
|
55 |
10K |
1 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
55
|
10K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
ejjwj
|
1.5K |
591K |
5 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
1.5K
|
591K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notification of cessation of securities - IXC
|
|
ejjwj
|
16 |
2.1K |
2 |
14/04/23 |
14/04/23 |
ASX - By Stock
|
16
|
2.1K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
ejjwj
|
241 |
48K |
1 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
241
|
48K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
ejjwj
|
241 |
48K |
2 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
241
|
48K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
IXC Charting Thread
|
|
ejjwj
|
523 |
95K |
2 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
523
|
95K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity update on NorthStar copper-67 production
|
|
ejjwj
|
34 |
13K |
3 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
34
|
13K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
ejjwj
|
241 |
48K |
1 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
241
|
48K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial
|
|
ejjwj
|
22 |
5.9K |
3 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
22
|
5.9K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial
|
|
ejjwj
|
22 |
5.9K |
5 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
22
|
5.9K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial
|
|
ejjwj
|
22 |
5.9K |
4 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
22
|
5.9K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial
|
|
ejjwj
|
22 |
5.9K |
10 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
22
|
5.9K
|
10
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
ejjwj
|
40 |
9.4K |
4 |
19/03/23 |
19/03/23 |
ASX - By Stock
|
40
|
9.4K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
What is IXC Management doing well ?
|
|
ejjwj
|
26 |
6.1K |
2 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
26
|
6.1K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Publication of Invex IIH Phase II Pressure Trial Results
|
|
ejjwj
|
20 |
4.0K |
3 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
20
|
4.0K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm to acquire Pharma15 Corporation
|
|
ejjwj
|
8 |
2.7K |
2 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
8
|
2.7K
|
2
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm to acquire Pharma15 Corporation
|
|
ejjwj
|
8 |
2.7K |
0 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
8
|
2.7K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm to acquire Pharma15 Corporation
|
|
ejjwj
|
8 |
2.7K |
1 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
8
|
2.7K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm to acquire Pharma15 Corporation
|
|
ejjwj
|
8 |
2.7K |
1 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
8
|
2.7K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: World leading expert in copper-67 joins Clarity SAB
|
|
ejjwj
|
5 |
2.5K |
1 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
5
|
2.5K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: 2022 Full Year Results Presentation
|
|
ejjwj
|
45 |
14K |
2 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
45
|
14K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
IXC Retail sell -$210k in fear, Instos buy $180k with glee, All in the last 10 days
|
|
ejjwj
|
74 |
11K |
1 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
74
|
11K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
ejjwj
|
241 |
48K |
5 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
241
|
48K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
IXC Retail sell -$210k in fear, Instos buy $180k with glee, All in the last 10 days
|
|
ejjwj
|
74 |
11K |
5 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
74
|
11K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
ejjwj
|
506 |
95K |
1 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
506
|
95K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
ejjwj
|
506 |
95K |
3 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
506
|
95K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
36 |
4.8K |
1 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
36
|
4.8K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
ejjwj
|
36 |
4.8K |
9 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
36
|
4.8K
|
9
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive topline results from SAR-bisPSMA diagnostic trial
|
|
ejjwj
|
17 |
9.6K |
4 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
17
|
9.6K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
ejjwj
|
1.5K |
591K |
2 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
1.5K
|
591K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
ejjwj
|
40 |
9.4K |
5 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
40
|
9.4K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Receives Approval for Paediatric Plan from the EMA
|
|
ejjwj
|
132 |
21K |
2 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
132
|
21K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
ejjwj
|
40 |
9.4K |
1 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
40
|
9.4K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Top 20 Holders
|
|
ejjwj
|
89 |
24K |
1 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
89
|
24K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Top 20 Holders
|
|
ejjwj
|
89 |
24K |
0 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
89
|
24K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Results of Meeting
|
|
ejjwj
|
53 |
7.5K |
1 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
53
|
7.5K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Results of Meeting
|
|
ejjwj
|
53 |
7.5K |
4 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
53
|
7.5K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Results of Meeting
|
|
ejjwj
|
53 |
7.5K |
1 |
27/11/22 |
27/11/22 |
ASX - By Stock
|
53
|
7.5K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
ejjwj
|
14 |
2.4K |
2 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
14
|
2.4K
|
2
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Application for quotation of securities - RAD
|
|
ejjwj
|
16 |
4.7K |
4 |
19/11/22 |
19/11/22 |
ASX - By Stock
|
16
|
4.7K
|
4
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Entitlement Offer - Extension of Retail Offer
|
|
ejjwj
|
13 |
4.6K |
2 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
13
|
4.6K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
ejjwj
|
234 |
85K |
2 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
234
|
85K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Shorters discover Telix
|
|
ejjwj
|
234 |
85K |
4 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
234
|
85K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
ejjwj
|
30 |
5.5K |
1 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
30
|
5.5K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
ejjwj
|
30 |
5.5K |
0 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
30
|
5.5K
|
0
|
|